<DOC>
	<DOCNO>NCT02833558</DOCNO>
	<brief_summary>Endoscopic submucosal dissection ( ESD ) endoscopic resection technique use treat superficial neoplasia gastrointestinal tract . Bleeding commonly encounter problem submucosal dissection usually manage electrocautery . However , carry risk deep thermal injury perforation . PuraStat® novel extracellular scaffold matrix amino acid form transparent adherent barrier apply bleed point . The aim trial study use PuraStat® reduce need thermal haemostasis ESD .</brief_summary>
	<brief_title>Purastat® vs Standard Therapy Haemostasis During Endoscopic Submucosal Dissection</brief_title>
	<detailed_description>Endoscopic submucosal dissection ( ESD ) endoscopic technique involve use endoscopic knife gently peel superficial neoplasia size en-bloc fashion . It meet principles onco-surgery associate excellent outcome . A difficulty however technique control bleed procedure . The GI mucosa vascular territory current method manage intraprocedural bleeding electrocautery use either endoscopic knife coag grasper . This introduce thermal injury bowel wall carry risk cause perforation cause pain . Furthermore , require precise target bleed vessel . Practically challenging , particularly coag grasper need bulky device difficult apply precisely location . PuraStat® ( 3-D Matrix Ltd , Tokyo ) liquid apply bleed area act rapidly form gel coat induces haemostasis . This transparent adherent barrier permit endoscopic therapy perform . It apply general area bleed require precise application exact point bleeding . It apply small catheter place biopsy channel endoscope use small space . PuraStat® license CE mark device use exudative haemorrhage vessel solid organ within GI tract . Given indication , role PuraStat ESD need explore could reduce need thermal haemostasis . This would significant clinical benefit ESD .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Gastrointestinal Hemorrhage</mesh_term>
	<mesh_term>Hemostatics</mesh_term>
	<criteria>Male Female , age 18 year . An ESD attempt clinical indication approve MDT . Oesophageal colonic lesion 25cm size Participant willing able give inform consent participation study Known coagulopathy likely affect risk bleed Submucosal tumour Anticoagulation antiplatelet therapy ( apart single modality aspirin clopidogrel ) stop clinical reason Patient preference</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Endoscopy , Gastrointestinal</keyword>
	<keyword>Endoscopic Submucosal Dissection</keyword>
	<keyword>Bleeding</keyword>
</DOC>